EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
TherapeuticsMD, Inc. (TXMD) had EBIT Margin of -270.30% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.76M |
|
$-2.18M |
|
-- |
|
$1.76M |
|
$6.52M |
|
$-4.76M |
|
$2.42M |
|
$-2.34M |
|
$-2.34M |
|
$-2.31M |
|
$-2.31M |
|
$-2.18M |
|
$-2.31M |
|
$-4.76M |
|
$-4.25M |
|
11.53M |
|
11.53M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$12.26M |
|
-- |
|
$26.56M |
|
$38.82M |
|
$5.17M |
|
-- |
|
$6.29M |
|
$11.45M |
|
$27.37M |
|
$23.05M |
|
$27.37M |
|
11.53M |
|
| Cash Flow Statement Financials | |
$1.17M |
|
-- |
|
$0.00M |
|
$4.33M |
|
$5.06M |
|
$0.73M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-270.30% |
|
|
EBIT Margin |
-270.30% |
-241.40% |
|
-133.05% |
|
-123.85% |
|
$1.17M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
0.49 |
|
738.29 |
|
-8.45% |
|
-10.03% |
|
-5.96% |
|
-8.45% |
|
$2.37 |
|
$0.10 |
|
$0.10 |
|